Kin KeeperSM: Reducing Disparities Through Cancer Literacy and Screening

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01910350

Acronym

KinKeeper

Enrollment

516

Registered

2013-07-29

Start date

2010-07-31

Completion date

2015-06-30

Last updated

2015-09-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Cervical Cancer

Keywords

Breast & cervical cancer prevention & screening

Brief summary

1\) To determine if the Kin KeeperSM Cancer Prevention Intervention increases first time and appropriately timed breast cancer screening rates among Black, Latina and Arab women; 2) To determine if the Kin KeeperSM Cancer Prevention Intervention increase first time and appropriately time cervical cancer screening rates among Black, Latina and Arab women; 3) To measure functional cancer literacy over time at the individual and familial level and 4) Assess rates of healthcare utilization cost among women in the Kin KeeperSM intervention and control-comparison groups.

Interventions

BEHAVIORALKin KeeperSM Cancer Prevention Intervention

OTHERStandard of care

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

SINGLE (Subject)

Eligibility

Sex/Gender

FEMALE

Age

21 Years to 70 Years

Healthy volunteers

Yes

Inclusion criteria

* Participants:self-identified as Black Latina and Arab women ho can recruit at least two bloodline female family members (mother daughter sister, etc.; can accommodate two in-home visits by a community health worker; and 21-70 years of age.

Exclusion criteria

* are not self-identified as Black, Latina, or Arab; do not have direct bloodline relatives; and are younger than 21 or older than 70 years of age.

Design outcomes

Primary

Measure	Time frame	Description
First time AND appropriately timed, clinical breast exam, mammogram, pap test	Baseline through 36 months.	Participants will complete measures every 6 months (baseline, 12 mo., 18 mo., 24 mo., 30 mo. & 36 mo.)to measure increases in screening rates for experimental vs. control group.

Secondary

Measure	Time frame	Description
Increased Breast and Cervical Cancer Literacy rates.	Baseline-36 months.	Do participants have a higher breast and cervical cancer literacy rates post intervention and over 36 months than control group as well as better retention?

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 21, 2026